Kangmei Pharma | 600518 - Ebitda





Ebitda Veränderung Datum
Akebia Therapeutics USD 14.03M 17.19M 2025-03
Alaunos Therapeutics USD -21.02M 1.33M 2021-03
Avita Medical AUD -9.69M 12.21M 2025-12
Cspc Pharmaceutical CNY 2.19B 21.88M 2024-12
Dianthus Therapeutics USD -46.46M 6.27M 2026-03
Genomma Lab Internacional MXN 976.34M 63.74M 2026-06
Hypermarcas BRL 642.42M 86.79M 2026-03
Ionis Pharmaceuticals USD -64.53M 135.49M 2026-03
IQVIA Holdings USD 994M 62M 2026-06
Jiangsu Hengrui CNY 2.56B 259.7M 2026-03
Kangmei Pharma CNY -12.72M 30.02M 2026-03
Moderna USD -1.26B 468M 2026-03
Organon & Co USD 371M 44M 2026-06
Revvity USD 228.18M 44.73M 2026-06
Sh Fosun Pharma CNY 1.65B 88.09M 2026-03
Tectonic Therapeutic USD -21.18M 365K 2025-12
Viatris USD 1.19B 138.8M 2026-06
WuXi AppTec CNY 7.98B 2.34B 2026-06
Xeris Pharmaceuticals USD 12.33M 12.76M 2026-03
Zhangzhou Pientzehuang Pharmaceutical CNY 882.7M 351.1M 2026-03